|
Volumn 28, Issue 2, 2004, Pages 207-217
|
Some drugs more equal than others: pseudo-generics and commercial practice.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
ARTICLE;
AUSTRALIA;
DRUG COST;
DRUG INDUSTRY;
ECONOMIC ASPECT;
ECONOMICS;
FEE;
HEALTH INSURANCE;
HUMAN;
LEGAL ASPECT;
MARKETING;
NOMENCLATURE;
PHARMACOKINETICS;
PUBLIC HEALTH;
STANDARD;
AUSTRALIA;
DRUG COSTS;
DRUG INDUSTRY;
DRUGS, GENERIC;
ECONOMIC COMPETITION;
FEES, PHARMACEUTICAL;
HUMANS;
INSURANCE, PHARMACEUTICAL SERVICES;
MARKETING;
NAMES;
NATIONAL HEALTH PROGRAMS;
THERAPEUTIC EQUIVALENCY;
|
EID: 16544387593
PISSN: 01565788
EISSN: None
Source Type: Journal
DOI: 10.1071/AH040207 Document Type: Article |
Times cited : (19)
|
References (0)
|